Check out our most popular compounded medications! Get Started
Bayview Pharmacy's compounded formulation of Ciclopirox 0.77%, Terbinafine HCl 1%, Clotrimazole 1%, and Betamethasone Dipropionate 0.05% is a topical cream dispensed in a pump mechanism. This semisolid preparation is designed for convenient and controlled application on the skin. It is used for localized treatment of Tinea Versicolor, Tinea Pedis, Tinea Cruris, Tinea Corporis, and Onychomycosis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical cream formulation of Ciclopirox 0.77%/Terbinafine HCl 1%/Clotrimazole 1%/Betamethasone Dipropionate 0.05%. This unique blend of active ingredients is specifically designed to address a range of skin conditions, including fungal infections, inflammation, and itching.
Ciclopirox, Terbinafine HCl, and Clotrimazole are all antifungal agents that function by inhibiting the growth of fungi responsible for skin infections. Betamethasone Dipropionate, on the other hand, is a corticosteroid that works to alleviate inflammation and itching. This combination of active ingredients creates a potent solution for treating a variety of skin conditions.
The cream is a semi-solid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. This allows for localized treatment or absorption of the active ingredients.
It is crucial to note that this formulation should not be used for more than two weeks without consulting a healthcare professional. Overuse or misuse can lead to potential side effects or reduced effectiveness of the medication.
If you have any queries about this formulation or how it can be utilized to treat your specific skin condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to assisting you in finding the most suitable treatment option for your needs.
Ciclopirox 0.77%/Terbinafine HCl 1%/Clotrimazole 1%/Betamethasone Dipropionate 0.05% Topical Cream is a compounded formulation designed for the treatment of various fungal skin infections. This semisolid preparation is dispensed in a pump mechanism, ensuring a convenient and controlled application on the skin for localized treatment or absorption of active ingredients.
It is specifically indicated for the treatment of tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm), and tinea versicolor (a condition that causes small, discolored patches of skin). This formulation is not recommended for use in the treatment of diaper rash, seborrheic dermatitis, or other fungal infections of the scalp or nails.
Patients are advised to avoid concomitant use of other topical medications, especially those containing corticosteroids, as it may interfere with the effectiveness of the treatment. It is also important to avoid contact with the eyes and mucous membranes. If contact occurs, it is recommended to rinse thoroughly with water.
If irritation or sensitization develops, discontinue use and consult a healthcare provider immediately. This formulation is designed to provide targeted relief from fungal skin infections, but it is essential to use it responsibly and under the guidance of a healthcare provider.
Ciclopirox 0.77%/Terbinafine HCl 1%/Clotrimazole 1%/Betamethasone Dipropionate 0.05% Topical Cream is a potent compounded formulation designed to address a range of skin conditions.
Ciclopirox, Terbinafine HCl, and Clotrimazole are all antifungal agents. Ciclopirox functions by inhibiting the growth of fungi, while Terbinafine HCl and Clotrimazole work by inhibiting the growth of both fungi and bacteria. These three ingredients together provide a broad-spectrum antifungal action.
Betamethasone Dipropionate, the fourth active ingredient, is a corticosteroid. It works by reducing inflammation and itching, providing relief from symptoms associated with inflammatory skin conditions such as eczema and psoriasis. This makes the cream a versatile treatment option for a variety of skin conditions.
When using Ciclopirox 0.77%/Terbinafine HCl 1%/Clotrimazole 1%/Betamethasone Dipropionate 0.05% Topical Cream, it is crucial to adhere to the directions provided by your healthcare provider. The cream is typically applied to the affected area twice daily, or as directed by your healthcare provider. Always wash your hands before and after applying the cream to prevent the spread of infection. If you experience any irritation or other side effects, discontinue use and contact your healthcare provider immediately.
If you have any questions or concerns about using Ciclopirox 0.77%/Terbinafine HCl 1%/Clotrimazole 1%/Betamethasone Dipropionate 0.05% Topical Cream, don't hesitate to reach out to your healthcare provider. They can provide you with the necessary guidance and support to ensure you get the most out of your treatment.
This compounded formulation is a topical cream that combines Ciclopirox 0.77%, Terbinafine HCl 1%, Clotrimazole 1%, and Betamethasone Dipropionate 0.05%. It is specifically designed for the treatment of various fungal skin infections including Tinea Versicolor, Tinea Pedis, Tinea Cruris, Tinea Corporis, and Onychomycosis. The inclusion of Betamethasone Dipropionate in the formulation provides anti-inflammatory properties, helping to alleviate inflammation and itching often associated with these conditions. The cream is dispensed in a pump mechanism, allowing for convenient and controlled application on the skin for localized treatment. It is crucial to adhere to the recommended usage duration of no longer than two weeks to avoid potential skin irritation and other adverse effects. For any queries or concerns regarding the use of this formulation, please do not hesitate to contact us.
This compounded formulation is used for the treatment of various skin conditions, including fungal infections. The active ingredients work together to inhibit the growth of fungi and reduce inflammation, itching, and redness.
This cream is designed for convenient and controlled application on the skin. Simply press the pump mechanism to dispense the cream, then apply it to the affected area as directed by your healthcare provider.
The active ingredients in this formulation are Ciclopirox 0.77%, Terbinafine HCl 1%, Clotrimazole 1%, and Betamethasone Dipropionate 0.05%.
Ciclopirox, Terbinafine HCl, and Clotrimazole are antifungal agents that inhibit the growth of fungi. Betamethasone Dipropionate is a corticosteroid that reduces inflammation, itching, and redness.
This cream is designed for localized treatment on the skin. However, it should not be used on the face, underarms, or groin unless directed by your healthcare provider.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply two doses at the same time.
Side effects may include skin irritation, burning, itching, or redness. If these symptoms persist or worsen, contact your healthcare provider immediately.
If you are pregnant or breastfeeding, consult your healthcare provider before using this cream. The active ingredients may be absorbed through the skin and could potentially affect the baby.
Store this cream at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children and pets.
If you suspect an overdose, contact a poison control center or emergency room immediately. Symptoms of overdose may include excessive redness, peeling, and discomfort at the application site.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
